Testing of biodegraphable materials in the form of thin film in vivo films (Q11934): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item)
(‎Removed claim: budget (P474): 13,228.800000000001 euro)
Property / budget
13,228.800000000001 Euro
Amount13,228.800000000001 Euro
UnitEuro
 
Property / budget: 13,228.800000000001 Euro / rank
Preferred rank
 
Property / budget: 13,228.800000000001 Euro / qualifier
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
 
Property / budget: 13,228.800000000001 Euro / qualifier
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 

Revision as of 22:08, 24 September 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Testing of biodegraphable materials in the form of thin film in vivo films
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    248,040.0 Czech koruna
    0 references
    9,921.6 Euro
    10 January 2020
    0 references
    330,720.0 Czech koruna
    0 references
    75 percent
    0 references
    1 May 2018
    0 references
    31 October 2018
    0 references
    31 October 2018
    0 references
    Contipro a.s.
    0 references
    0 references

    49°59'36.92"N, 16°29'45.42"E
    0 references
    56102
    0 references
    Projekt je zaměřen na řešení problematiky biokompatibility, biodegradace a fyzikálních změn unikátních materiálů - tenkých filmů na bázi modifikovaného hyaluronanu v savčím organismu. Budou sledovány vlastnosti těchto filmů po jejich implantaci a budou stanovovány parametry jejich biokompatibility a degradace definovaných na základě požadovaných vlastností zdravotních prostředků pro jejich uplatnění v chirurgii. a. (Czech)
    0 references
    The project aims at addressing the issue of biocompatibility, biodegradation and physical modifications of unique materials — modified hyaluronant film in a mammalian organism. The properties of these films after their implantation will be monitored and the parameters of their biocompatibility and degradation defined on the basis of the required properties of the medical devices for their use in the surgeon. (English)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_115/0012572
    0 references